CHEBI:53559 - topoisomerase IV inhibitor

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name topoisomerase IV inhibitor
ChEBI ID CHEBI:53559
Definition A topoisomerase inhibitor that inhibits DNA topoisomerase IV, which catalyses ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands.
Stars This entity has been manually annotated by the ChEBI Team.
ChEBI Ontology
Outgoing topoisomerase IV inhibitor (CHEBI:53559) is a topoisomerase inhibitor (CHEBI:70727)
Incoming ciprofloxacin (CHEBI:100241) has role topoisomerase IV inhibitor (CHEBI:53559)
ciprofloxacin dihydrochloride (CHEBI:59938) has role topoisomerase IV inhibitor (CHEBI:53559)
ciprofloxacin hydrochloride (anhydrous) (CHEBI:310388) has role topoisomerase IV inhibitor (CHEBI:53559)
ciprofloxacin hydrochloride hydrate (CHEBI:59936) has role topoisomerase IV inhibitor (CHEBI:53559)
coumermycin A1 (CHEBI:3907) has role topoisomerase IV inhibitor (CHEBI:53559)
dextrofloxacin (CHEBI:46577) has role topoisomerase IV inhibitor (CHEBI:53559)
fleroxacin (CHEBI:31810) has role topoisomerase IV inhibitor (CHEBI:53559)
flumequine (CHEBI:85267) has role topoisomerase IV inhibitor (CHEBI:53559)
gemifloxacin (CHEBI:101853) has role topoisomerase IV inhibitor (CHEBI:53559)
gemifloxacin mesylate (CHEBI:53749) has role topoisomerase IV inhibitor (CHEBI:53559)
levofloxacin (CHEBI:63598) has role topoisomerase IV inhibitor (CHEBI:53559)
ofloxacin (CHEBI:7731) has role topoisomerase IV inhibitor (CHEBI:53559)
tosufloxacin (CHEBI:77573) has role topoisomerase IV inhibitor (CHEBI:53559)
tosufloxacin tosylate (CHEBI:77605) has role topoisomerase IV inhibitor (CHEBI:53559)
tosufloxacin tosylate hydrate (CHEBI:32248) has role topoisomerase IV inhibitor (CHEBI:53559)
trovafloxacin (CHEBI:9763) has role topoisomerase IV inhibitor (CHEBI:53559)
trovafloxacin mesylate (CHEBI:77568) has role topoisomerase IV inhibitor (CHEBI:53559)
Synonym Source
topoisomerase IV inhibitors ChEBI
Last Modified
23 November 2022